Godrej Agrovet Ltd
Godrej Agrovet Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Astec LifeSciences: Targeting around 15%-20% top-line growth, with CDMO segment expected to grow slightly higher than the enterprise segment; margins to remain intact. Godrej Agrovet aims for early double-digit revenue growth at the consolidated level for FY27.
From Godrej Agrovet Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Astec LifeSciences: Targeting around 15%-20% top-line growth, with CDMO segment expected to grow slightly higher than the enterprise segment; margins to remain intact. CDMO revenue share aimed at 52%-53%+.
- Animal Nutrition: Strong volume growth continuing, particularly in cattle feed and newly launched products; focusing on volume-driven revenue growth with double-digit growth expected.
- Oil Palm: Early double-digit volume growth expected, with record area expansion planned; improving oil extraction ratio supports margins.
- Crop Care: Expected strong recovery from Q2 FY27 onwards, aiming for very high double-digit revenue growth post inventory normalization.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Godrej Agrovet Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Godrej Agrovet plans capex of around INR 350-400 crores per year going forward.
- Approximately 75%-80% of capex will be growth-oriented.
- Around 50% of total capex deployment is targeted toward the Oil Palm business.
- Specific investments include rolling out a specialty fat refinery starting May FY '27, expected to ramp up in the second half of the year.
- Investment focus on value-added products in Oil Palm to move the portfolio towards 50%-55% value-added products by FY31.
- Ongoing strategic restructuring and portfolio reviews to unlock shareholder value over a 4-5 year horizon.
2 more points management made on capital expenditure plans
Top-ranked in Food Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Godrej Agrovet Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Godrej Agrovet Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.3K Cr, net profit ₹102 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Godrej Agrovet's management said in earlier quarters
Others in Food Products this season
- Mukka Proteins Ltd (Q4 FY26)
Q4 FY26 Revenue from Operations:** ₹381.6 Cr . Key concall takeaways from Mukka Proteins Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
- Shri Ahimsa Naturals Ltd (Q4 FY26)
Revenue figures (₹ in Crs) for FY: . Key concall takeaways from Shri Ahimsa Naturals Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
- Prataap Snacks Ltd (Q4 FY26)
Q4 FY26 revenue from operations was ₹418.1 crore (₹4,180.6 Mn), up 4.9% YoY from ₹398.5 crore (₹3,985.2 Mn) in Q4 FY25. Key concall takeaways from Prataap…
- Proventus Agrocom Ltd (Q4 FY26)
Reported revenue for FY26: ₹659 Cr, a ~58% increase YoY vs FY25 (Page 26, 14). Key concall takeaways from Proventus Agrocom Ltd's Q4 FY26 earnings call — and…
Frequently Asked Questions
What were Godrej Agrovet Ltd Q4 FY26 results?
Astec LifeSciences: Targeting around 15%-20% top-line growth, with CDMO segment expected to grow slightly higher than the enterprise segment; margins to remain intact. Godrej Agrovet aims for early double-digit revenue growth at the consolidated level for FY27.
What is Godrej Agrovet Ltd share price analysis?
Godrej Agrovet Ltd currently shows a neutral. The stock trades at a P/E of 23.8 with a market cap of ₹11,166 Cr. Investors should review the full earnings analysis for detailed insights.
Is Godrej Agrovet Ltd planning capital expenditure?
Godrej Agrovet plans capex of around INR 350-400 crores per year going forward.
Keep Godrej Agrovet Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.